Detalhe da pesquisa
1.
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 387(10023): 1066-1074, 2016 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025186
2.
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.
Br J Cancer
; 114(8): 889-96, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002938
3.
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit.
Gastric Cancer
; 17(4): 621-629, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24445485
4.
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
Lancet Oncol
; 14(9): 882-92, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810788
5.
Ovarian cancer: strategies for overcoming resistance to chemotherapy.
Nat Rev Cancer
; 3(7): 502-16, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12835670
6.
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
N Engl J Med
; 361(2): 123-34, 2009 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19553641
7.
Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
Radiology
; 265(2): 426-36, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891356
8.
Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors.
Invest New Drugs
; 30(2): 616-28, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20927639
9.
PARP inhibitors: the race is on.
Br J Cancer
; 114(7): 713-5, 2016 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022824
10.
Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients.
Radiology
; 261(1): 182-92, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21828186
11.
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.
EMBO Mol Med
; 13(5): e13366, 2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709473
12.
PARP inhibition: targeting the Achilles' heel of DNA repair to treat germline and sporadic ovarian cancers.
Curr Opin Oncol
; 22(5): 473-80, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20485165
13.
Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation.
Lung Cancer
; 148: 12-19, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771715
14.
Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services.
Eur J Cancer
; 114: 97-106, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078974
15.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Eur J Cancer
; 120: 132-139, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522033
16.
Identifying prognostic signatures in the blood of ovarian cancer patients.
Gynecol Oncol
; 128(1): 1-2, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23273138
17.
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Clin Cancer Res
; 13(23): 7191-8, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056200
18.
10th Biennial Helene Harris Memorial Trust meeting.
Cancer Res
; 66(6): 2904-6, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16540635
19.
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials.
Eur J Cancer
; 95: 20-29, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29614442
20.
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials.
Eur J Cancer
; 101: 55-61, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025230